IDEAS home Printed from https://ideas.repec.org/a/eee/hepoli/v91y2009isupplement1ps15-s25.html
   My bibliography  Save this article

Smoking cessation: How compelling is the evidence? A review

Author

Listed:
  • Tønnesen, Philip

Abstract

Objectives To provide a short review of the evidence base supporting smoking cessation interventions, including behavioral therapy and pharmacological treatment options.Methods Published meta-analysis was mainly used supplemented with a limited literature search.Results Effective smoking cessation consists of pharmacotherapy and behavioral support. Counseling increases abstinence rates parallel to the intensity of support. First-line pharmacological drugs for smoking cessation are nicotine replacement products (patch, gum, inhaler, nasal spray, lozenge/tablets), varenicline and bupropion SR with scientific well-documented efficacy when used for 2-3 months and mostly mild side effects. Alternative therapies such as hypnosis and acupuncture have no scientifically proven effects.Conclusions With the most optimal drugs and counseling today a 1-year abstinence rate of approximately 25% can be expected in smoking cessation. On-going research is examining the potential effects of nicotine vaccination as relapse prevention.

Suggested Citation

  • Tønnesen, Philip, 2009. "Smoking cessation: How compelling is the evidence? A review," Health Policy, Elsevier, vol. 91(Supplemen), pages 15-25, July.
    • Handle: RePEc:eee:hepoli:v:91:y:2009:i:supplement1:p:s15-s25
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0168-8510(09)70004-1
    Download Restriction: Full text for ScienceDirect subscribers only
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Maynard, Alan, 1991. "Developing the Health Care Market," Economic Journal, Royal Economic Society, vol. 101(408), pages 1277-1286, September.
    2. P.M.H., Maureen & Mölken, Rutten-Van & Van Doorslaer, Eddy K. A. & Rutten, Frans F. H., 1992. "Economic appraisal of asthma and COPD care: A literature review 1980-1991," Social Science & Medicine, Elsevier, vol. 35(2), pages 161-175, July.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Isabella Bonacci & Andrea Mazzitelli & Donato Morea, 2020. "Evaluating Climate between Working Excellence and Organizational Innovation: What Comes First?," Sustainability, MDPI, vol. 12(8), pages 1-29, April.
    2. Karen Gerard & Gavin Mooney, 1993. "Qaly league tables: Handle with care," Health Economics, John Wiley & Sons, Ltd., vol. 2(1), pages 59-64, April.
    3. Kobelt, G., 2013. "Health Economics: An Introduction to Economic Evaluation," Monographs, Office of Health Economics, number 000004.
    4. Maureen P. M. H. Rutten‐van Mölken & Eddy K. A. Van & René C. J. A. van Vliet, 1994. "Statistical analysis of cost outcomes in a randomized controlled clinical trial," Health Economics, John Wiley & Sons, Ltd., vol. 3(5), pages 333-345, September.
    5. Ham, Chris, 1997. "Priority setting in health care: learning from international experience," Health Policy, Elsevier, vol. 42(1), pages 49-66, October.
    6. Hanlon, G., 1997. "Commercialising the service class and economic restructuring--a response to my critics," Accounting, Organizations and Society, Elsevier, vol. 22(8), pages 843-855, November.
    7. Robinson, Ray, 1999. "Limits to rationality: economics, economists and priority setting," Health Policy, Elsevier, vol. 49(1-2), pages 13-26, September.
    8. Milne, Robin G. & Torsney, Ben, 1997. "The Efficiency of Administrative Governance: The Experience of the Pre-reform British National Health Service," Journal of Comparative Economics, Elsevier, vol. 24(2), pages 161-180, April.
    9. Eulàlia Dalmau & Jaume Puig, 1997. "Market structure and hospital efficiency: Evaluating potential effects of deregulation in a national health service," Economics Working Papers 214, Department of Economics and Business, Universitat Pompeu Fabra.
    10. Michael Drummond & Bernie O'Brienm, 1993. "Clinical importance, statistical significance and the assessment of economic and quality‐of‐life outcomes," Health Economics, John Wiley & Sons, Ltd., vol. 2(3), pages 205-212, October.
    11. Propper, Carol, 1996. "Market structure and prices: The responses of hospitals in the UK National Health Service to competition," Journal of Public Economics, Elsevier, vol. 61(3), pages 307-335, September.
    12. S. M. A. A. Evers & A. S. Van Wijk & A. J. H. A. Ament, 1997. "Economic Evaluation of Mental Health Care Interventions. A Review," Health Economics, John Wiley & Sons, Ltd., vol. 6(2), pages 161-177, March.
    13. Ágota Szende & Z. Mogyorósy & N. Muszbek & J. Nagy & G. Pallos & C Dözsa, 2002. "Methodological guidelines for conducting economic evaluation of healthcare interventions in Hungary: a Hungarian proposal for methodology standards," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 3(3), pages 196-206, September.
    14. Mike Drummond & Alastair McGuire & Astrid Fletcher, 1993. "Economic evaluation of drug therapy for hypercholesterolaemia in the United Kingdom," Working Papers 104chedp, Centre for Health Economics, University of York.
    15. Eulàlia Dalmau & Jaume Puig, 1997. "Market structure and hospital efficiency: Evaluating potential effects of deregulation in a national health service," Working Papers, Research Center on Health and Economics 214, Department of Economics and Business, Universitat Pompeu Fabra.
    16. Eulália Dalmau-Atarrodona & Jaume Puig-Junoy, 1998. "Market Structure and Hospital Efficiency: Evaluating Potential Effects of Deregulation in a National Health Service," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 13(4), pages 447-466, August.
    17. Mark Blaug, 1998. "Where are we now in British health economics?," Health Economics, John Wiley & Sons, Ltd., vol. 7(S1), pages 63-78, August.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:91:y:2009:i:supplement1:p:s15-s25. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.